MEDICAL MARIJUANA: RULING PROTECTS PRESCRIBING PHYSICIANS
Contending that federal medical marijuana policies "violateThis is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
a doctor's right to free speech as well as the patient-physician
relationship," U.S. District Court Judge Fern Smith ruled
yesterday that the Justice Department "cannot interfere with
doctors who recommend marijuana to seriously ill patients," SAN
FRANCISCO CHRONICLE. Smith wrote, "The government's fear that
frank dialogue between physicians and patients about medical
marijuana might foster drug use" doesn't justify putting
restrictions on a doctor's ability "to talk frankly with a
patient" (Wallace, 5/1). The ruling applies only to physicians
treating patients with HIV/AIDS, glaucoma, cancer, or certain
"chronic, debilitating" muscle seizures; doctors will be allowed
to "recommend marijuana to patients as long as they do not help
them obtain the drug," SAN FRANCISCO EXAMINER reports (Lat, 5/1).
Judge Smith issued yesterday's temporary injunction in a class
action lawsuit filed earlier this year by a group of California
doctors and patients who opposed the Clinton administration's
"threatened ... crackdown" on doctors who prescribe marijuana to
patients (see AHL 2/10). The injunction will remain in place
until the lawsuit is heard at trial, unless a higher court
overturns Smith's ruling (LaGanga/Bailey, LOS ANGELES TIMES,
5/1).
VOLLEYS: Graham Boyd, lead attorney for the plaintiffs,
called the ruling a "first round triumph," also noting that it
"means the federal war on drugs, which became a war on doctors,
has changed dramatically" (EXAMINER, 5/1). "I think the judge
hammered the federal government for a policy of threatening
doctors and for interfering with patients' health care," Boyd
said (CHRONICLE, 5/1). The TIMES reports that Clinton
administration officials "were scurrying to find holes in Smith's
ruling, but refused to speculate on whether they might appeal."
Bob Weiner, a spokesperson for the White House Office of National
Drug Control Policy, said, "This ruling has a lot of ingredients
to it" (5/1). He added, "I understand that this is a 42-page
document, and there are a lot of complicated issues involved. We
haven't seen the ruling yet. We are looking forward to reviewing
it and figuring out where we stand" (CHRONICLE, 5/1).